Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jul 8, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prelude Therapeutics Inc
| 6.03K |
$3.60 | -$12,049.20 | +11.75% | 57.31K | +1 |
Jul 4
| ||||||
Protara Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 7
| |||||||
Prelude Therapeutics Inc
| 6.03K |
$4.74 | -$15,864.78 | +13.32% | 51.29K | +1 |
Apr 4
| ||||||
Prelude Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Mar 1
| ||||||
Prelude Therapeutics Inc
| 5.53K |
$3.77 | -$14,491.88 | +13.92% | 45.26K | +1 |
Jan 4
| ||||||
Prelude Therapeutics Inc
| 9.38K |
—
|
—
| +30.89% | 39.73K | +1 |
Oct 4
| ||||||
Prelude Therapeutics Inc
| 6.13K |
$4.65 | -$15,075.30 | +25.32% | 30.35K | +1 |
Jul 4
| ||||||
Protara Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 7
| |||||||
Prelude Therapeutics Inc
| 24.22K |
$6.12 | -$81,273.60 |
∞
| 24.22K | +1 |
Apr 4 - Apr 6
| ||||||
Prelude Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 7
| ||||||
Protara Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Prelude Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
May 2
| ||||||
Prelude Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Beigene, Ltd.
|
0
|
$199.05 | -$237,271.00 |
—
|
0
| +1 |
Dec 14
|
Scheduled
| |||||
Beigene, Ltd.
| 14.82K |
$359.86 | -$377,492.69 | +10.20% | 160.06K | +1 |
Nov 30 - Dec 1
| ||||||
Beigene, Ltd.
|
0
|
$250.65 | -$392,063.39 |
—
|
0
| +1 |
Nov 17
|
Scheduled
| |||||
Beigene, Ltd.
|
0
|
$246.37 | -$379,223.00 |
—
|
0
| +1 |
Oct 19
|
Scheduled
| |||||
Beigene, Ltd.
|
0
|
$258.96 | -$1,668,013.97 |
—
|
0
| +1 |
Sep 20
|
Scheduled
| |||||
Beigene, Ltd.
| -12.90K |
$358.14 | -$4,620,389.59 | -100.00% |
0
| +1 |
Sep 13
|
Scheduled
| |||||
Beigene, Ltd.
| 14.29K |
$318.88 | -$346,620.90 | +4.78% | 312.95K | +1 |
Aug 31 - Sep 2
| ||||||
Beigene, Ltd.
|
0
|
$239.66 | -$3,895,768.97 |
—
|
0
| +1 |
Jul 15
|
Scheduled
| |||||
Beigene, Ltd.
| -425.00 |
$192.23 | -$639,088.00 | -100.00% |
0
| +1 |
Jun 28 - Jun 29
|
Scheduled
| |||||
Beigene, Ltd.
| 24.88K |
$325.66 | -$152,733.04 | +8.91% | 304.19K | +1 |
Jun 16 - Jun 18
| ||||||
Protara Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Protara Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Beigene, Ltd.
| -603.00 |
$351.55 | -$211,985.55 | -100.00% |
0
| +1 |
Jun 7
| ||||||
Beigene, Ltd.
| 7.19K |
$194.48 | -$686,045.79 | +2.51% | 293.31K | +1 |
May 28 - Jun 1
|
Scheduled
| |||||
Beigene, Ltd.
|
0
|
$192.21 | -$488,151.99 |
—
|
0
| +1 |
Apr 29
|
Scheduled
| |||||
Beigene, Ltd.
|
0
|
$176.75 | -$441,757.55 |
—
|
0
| +1 |
Mar 29
|
Scheduled
| |||||
Beigene, Ltd.
|
0
|
$175.11 | -$436,863.99 |
—
|
0
| +1 |
Feb 26
|
Scheduled
| |||||
Beigene, Ltd.
|
0
|
$176.24 | -$440,257.15 |
—
|
0
| +1 |
Jan 29
|
Scheduled
| |||||
Beigene, Ltd.
|
0
|
$139.31 | -$329,455.01 |
—
|
0
| +1 |
Dec 29
|
Scheduled
| |||||
Beigene, Ltd.
|
0
|
$148.66 | -$357,487.52 |
—
|
0
| +1 |
Nov 30
|
Scheduled
| |||||
Beigene, Ltd.
|
0
|
$164.78 | -$405,858.01 |
—
|
0
| +1 |
Oct 29
|
Scheduled
| |||||
Beigene, Ltd.
|
0
|
$154.94 | -$376,333.28 |
—
|
0
| +1 |
Sep 29
|
Scheduled
| |||||
Beigene, Ltd.
| -3.13K |
$233.07 | -$729,045.04 | -100.00% |
0
| +1 |
Sep 3
|
Scheduled
| |||||
Beigene, Ltd.
|
0
|
$135.85 | -$638,156.31 |
—
|
0
| +1 |
Aug 28
|
Scheduled
| |||||
Beigene, Ltd.
|
0
|
$152.44 | -$344,952.02 |
—
|
0
| +1 |
Jul 29
|
Scheduled
| |||||
Beigene, Ltd.
|
0
|
$180.20 | -$155,271.60 |
—
|
0
| +1 |
Jul 7
|
Scheduled
| |||||
Beigene, Ltd.
| -435.00 |
$145.26 | -$407,940.46 | -100.00% |
0
| +1 |
Jun 26 - Jun 29
|
Scheduled
| |||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.